DNLI
Denali Therapeutics Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -10.3% · posisi baru bersih -5.3% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 14.83K | $276,801 | n/a | n/a |
| Q2 2026 | 97 | +6 | 103.66M | $2.65B | +11 | −4 |
| Q1 2026 | 93 | +4 | 96.77M | $1.85B | +11 | −8 |
| Q4 2025 | 89 | 0 | 110.68M | $1.83B | +1 | n/a |
| Q3 2025 | 19 | 0 | 67.26M | $976.61M | n/a | −1 |
| Q2 2025 | 17 | +1 | 74.76M | $1.05B | +2 | −1 |
| Q1 2025 | 13 | +1 | 44.98M | $611.55M | +2 | −1 |
| Q4 2024 | 12 | -1 | 38.31M | $780.78M | n/a | −1 |
| Q3 2024 | 12 | 0 | 34.10M | $993.27M | +1 | −1 |
| Q2 2024 | 12 | n/a | 35.56M | $825.78M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 12.29M | +2.0% | $178.45M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (pasif) | 11.99M | +1.5% | $174.14M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | Baillie Gifford ✦ | 11.59M | -3.0% | $168.31M | 0.1% | ▼ Trim | 6 | SEC ↗ ×4 |
| 4 | Fidelity (FMR) ✦ | 6.34M | -15.9% | $92.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 5 | State Street Global Advisors ✦ (pasif) | 5.46M | +20.9% | $79.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 4.57M | -30.6% | $66.33M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (pasif) | 3.47M | +9.3% | $50.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 2.52M | +13.8% | $36.58M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 2.16M | n/a | $31.42M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Morgan Stanley ✦ | 1.69M | n/a | $24.53M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 11 | Fisher Asset Management ✦ | 1.63M | +7.6% | $23.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Millennium Management ✦ | 1.31M | +45.2% | $18.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Marshall Wace ✦ | 787.03K | -44.0% | $11.43M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 688.22K | -44.9% | $9.99M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | JPMorgan Chase ✦ | 350.04K | n/a | $5.08M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 16 | Two Sigma Investments ✦ | 266.29K | +1279.8% | $3.87M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 59.80K | -69.4% | $868,296 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 59.23K | -99.0% | $860,078 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 19 | AQR Capital Management ✦ | 24.14K | +13.8% | $350,498 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Norges Bank | $55.22M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 265 pemegang, 147.10M saham, $2.60B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 1.65K lbr · $36,868
Director · 10.82K lbr · $247,328
Director · 615 lbr · $14,600
Officer · 2.77K lbr · $64,882
Officer · 2.86K lbr · $71,625
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi